J.P. Morgan Securities LLC
383 Madison Avenue
New York, New York 10179
Jefferies LLC
520 Madison Avenue
New York, New York 10022
Cowen and Company, LLC
599 Lexington Avenue
New York, NY 10022
November 16, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, D.C. 20549-6010
Attn: Donald Field and Dietrich King
Re: Olema Pharmaceuticals, Inc.
Registration Statement on Form S-1, as amended (File No. 333-249748)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, we, as representatives of the several underwriters, hereby join in the request of Olema Pharmaceuticals, Inc. (the “Company”) that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on November 18, 2020, at 2:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant or its outside counsel, Cooley LLP, may orally request via telephone call to the staff of the Commission.
Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that we have carried out the following distribution of the Company’s preliminary prospectus dated November 16, 2020:
| (i) | Dates of distribution: November 16, 2020 through the date hereof |
| (ii) | Number of prospective underwriters to which the preliminary prospectus was furnished: 4 |
| (iii) | Number of preliminary prospectuses furnished to investors: approximately 1,905 |
| (iv) | Number of preliminary prospectuses distributed to others, including the Company, the Company’s counsel, independent accountants and underwriters’ counsel: approximately 25 |
The undersigned, as representatives of the several underwriters, advise that they have complied and will continue to comply, and each other participating underwriter has advised the undersigned that it has complied and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Signature Page Follows]
| Very truly yours, |
J.P. MORGAN SECURITIES LLC
Acting on behalf of themselves and the several underwriters |
| J.P. MORGAN SECURITIES LLC | |||
| By: | /s/ David Ke | ||
| Name: | David Ke | ||
| Title: | Executive Director | ||
| JEFFERIES LLC | |||
| By: | /s/ Michael Brinkman | ||
Name: Title: |
Michael Brinkman Managing Director | ||
| COWEN AND COMPANY, LLC | |||
| By: | /s/ Mariel A. Healy | ||
| Name: | Mariel A. Healy | ||
| Title: | Managing Director | ||
[Signature Page - Underwriters' Acceleration Request]